• Company
  • News
  • Investors
  • Contacts
  • Careers
polypeptide-logopolypeptide-logologo-mobilepolypeptide-logo
  • Services
    • GMP Compliance
    • Pre-GMP development
    • Production
    • Quality Assurance
    • Quality control
    • Regulatory Support
  • Commercial Manufacturing
    • Commercial products at PolyPeptide
    • Late stage development
    • Process development and optimization
    • Capacity and Capabilities
  • Custom R&D
    • Custom Research Grade Peptides
    • Radiolabeled peptide
  • Generic peptides
  • Oligos
  • Services
    • GMP Compliance
    • Pre-GMP development
    • Production
    • Quality Assurance
    • Quality control
    • Regulatory Support
  • Commercial Manufacturing
    • Commercial products at PolyPeptide
    • Late stage development
    • Process development and optimization
    • Capacity and Capabilities
  • Custom R&D
    • Custom Research Grade Peptides
    • Radiolabeled peptide
  • Generic peptides
  • Oligos
✕
  • Home
  • News
  • Expert views
  • Poster: Focus on Controlling Non-peptide Impurities in Peptide API Manufacturing

Poster: Focus on Controlling Non-peptide Impurities in Peptide API Manufacturing

2012
Expert views

Detection, Identification and Removal of a DTT-di-t-Bu Adduct Formed in Peptide Resin TFA Cleavages […]

In contemporary peptide API manufacturing considerable resources are devoted to development of analytical methods suitable for the detection of impurities.2 While these methods are typically quite adequate for the detection of peptide-related impurities, they may not be equally suited for the detection of minute amounts of low MW non-peptide entities. Nevertheless, small molecule  reagents, reactants, solvents as well as amino acid protecting groups can be encountered throughout any peptide API manufacturing process. Incomplete removal of such compounds and/or formation of new small molecules during the manufacturing can compromise the quality of a peptide API.

Jan Pawlas,1 Stefan Hansen, Thomas Svensson and Gunnar Stærkær, EuroPeptides 2012

Read more

Back to news

Related posts

2 April 2025

Expanding the Reach of Sustainable Solid-Phase Peptide Synthesis


Read more
20 March 2025

Impurities in Peptide Drug Substance and Challenges Faced during Registration (in US, EU, Brazil and China Markets) and Commercial Phase


Read more
13 November 2024

Peptide Manufacturing: Rethinking the Technology Platform for Large Scale Demand


Read more

Polypeptide Group

INFO

COMPANY
LEADERSHIP
CONTACTS
CAREERS

NEWS

LATEST NEWS
SIGN UP FOR NEWS
EVENTS

SOCIALS

LINKEDIN
YOUTUBE
© Confidentiality 2025 PolyPeptide Group • Cookie Policy • Sitemap • Privacy policy
    • Company
    • News
    • Investors
    • Contacts
    • Careers